142 related articles for article (PubMed ID: 7530480)
1. PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogenous leukaemia blasts.
Stafford HA; Nagarajan S; Weinberg JB; Medof ME
Br J Haematol; 1995 Jan; 89(1):72-8. PubMed ID: 7530480
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
3. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone.
Devine DV; Gluck WL; Rosse WF; Weinberg JB
J Clin Invest; 1987 Jan; 79(1):314-7. PubMed ID: 2432090
[TBL] [Abstract][Full Text] [Related]
5. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
6. Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.
Stafford HA; Tykocinski ML; Lublin DM; Holers VM; Rosse WF; Atkinson JP; Medof ME
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):880-4. PubMed ID: 2448783
[TBL] [Abstract][Full Text] [Related]
7. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a human T-cell line with deficient surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins from a patient with paroxysmal nocturnal haemoglobinuria.
Masuda T; Yonemura Y; Fujimoto K; Hidaka M; Nagakura S; Nakakuma H; Hata H; Sanada I; Kawakita M; Takatsuki K
Br J Haematol; 1994 May; 87(1):24-30. PubMed ID: 7524616
[TBL] [Abstract][Full Text] [Related]
9. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
10. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
Kawakami Z; Ninomiya H; Tomiyama J; Abe T
Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
[TBL] [Abstract][Full Text] [Related]
12. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.
Carothers DJ; Hazra SV; Andreson SW; Medof ME
J Clin Invest; 1990 Jan; 85(1):47-54. PubMed ID: 1688570
[TBL] [Abstract][Full Text] [Related]
14. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
16. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor.
Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T
Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930
[TBL] [Abstract][Full Text] [Related]
17. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
18. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.
Hillmen P; Bessler M; Crawford DH; Luzzatto L
Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma decay-accelerating factor levels in paroxysmal nocturnal hemoglobinuria.
Nakakuma H; Nagakura S; Kawaguchi T; Horikawa K; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Int J Hematol; 1992 Apr; 55(2):121-5. PubMed ID: 1380843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
